NEWS

2022.11.18

Press Releases

Announcement of Licensing by Japan Innovative Therapeutics, Inc. of Corneal Endothelium Therapeutic Agents

2022.08.08

Press Releases

Aiming at Early Commercialization of Regenerative Medicine for Corneal Endothelium Manufacturing of regenerative medical product candidate AE101 starting at J-TEC

2022.08.03

Press Releases

Announcement of Appointment of Outside Director

2022.06.30

Press Releases

Conclusion of Joint Development Agreement for Corneal Endothelial Regenerative Medicine Product AE-101, and Series B Funding through Third-Party Allocation of Shares

2022.05.31

Press Releases

Santen and ActualEyes start registering patients to participate in Phase II clinical trial （Phase IIa / PoC study, PHANTOM study）for Fuchs endothelial corneal dystrophy

This website uses cookies for the purpose of operating our services and improving the user experience. For details, please refer to our privacy policy. By clicking on the “Agree” button or continuing to use our website, you will be regarded as having agreed to our use of cookies.